Ph.D., fmr. Executive Vice President of Biopharmaceuticals R&D at AstraZeneca Director since 2025 Age 59 Board Committee Compensation and Management Development Key Skills Executive Leadership and Business Operations Commercial Drug Development Healthcare and Pharma Leadership International Business Public Board Service Government and Public Policy Medicine and Scientific Research Relevant Expertise Dr. Pangalos has over 30 years of experience researching and developing medicines gained through research and development roles across a number of pharmaceutical and biotechnology companies. Dr. Pangalos expertise enhances Board perspectives on the development and execution of corporate strategy, drug development and managing risks. Career Highlights Executive Vice President of Biopharmaceuticals R&D, AstraZeneca (2019 2024) Executive Vice President of Early R&D, AstraZeneca (2010 2018) Senior Vice President, Pfizer (2008 2010) Vice President Neuroscience, Wyeth (2003 2008) Fellow of the Royal Society, the Academy of Medical Sciences, the Royal Society of Biology and Clare Hall, University of Cambridge Other Public Company Boards Absci Corporation (since 2024) Education Bachelor of Science in Biochemistry and Molecular Biology from Imperial College London Ph.D. in Neuropharmacology from University College London